Clinical Trial Update: Evolocumab or Normal Strategies to Reach LDL Objectives in Acute Myocardial Infarction Upbound to PCI [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating evolocumab versus standard LDL-lowering strategies to achieve LDL targets in acute myocardial infarction patients undergoing P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST Segment Elevation MI | Phase 4 | Status: ACTIVE_NOT_RECRUITING